Resource

Keeping Patients at the Heart of Clinical Trials

Clinical trial patient recruitment continues to be challenging. Even with shifts to decentralize clinical trials and the addition of new vendors and technology, recruitment still is the primary cause of delays or discontinuation. What could we be missing? In this webinar, we’ll discuss the current state of clinical trials, historical challenges of recruitment, and new thinking to integrate human touch and improve retention. We will share frameworks and methodologies you...

Resource

Buyer’s Guide: PV Reporting AI and Automation

Considerations for selecting modern pharmacovigilance (PV) and safety solutions that improve adverse event detection, assessment, understanding and prevention. Download your copy to gain expert insights into developing and implementing a robust automation strategy for PV & Safety workflows. ...

Resource

LifeSci Talks COA Series | Decoding Decentralized Trials: Navigating Novel Decentralized Research Challenges and Complexity

DCTs have picked up significantly in previous years, catalyzed by the pandemic and a move to remote research. With this move comes a host of new challenges, including those surrounding technical interoperability, resistance to adopting new technologies, and the need for flexibility in technology uptake at research sites. With additional considerations to be made, such as ensuring regulatory compliance, and enforcing standardized metrics in assessing DCT performance, this...

Data Annotation for Life Sciences

At DataForce, we specialize in elevating real-world clinical data through precise and efficient annotation services. From real-time adverse event (AE) detection for pharmacovigilance to social listening for trend identification, our expertly annotated datasets empower AI models, fostering innovation and success in clinical research and development.....

Resource

Data Standardization COA Whitepaper

With the surge of eCOA providers deploying differing technology platforms with differing architecture and file exchange processes, the landscape is shifting and becoming opaque. Deploying an eCOA solution faster and more costeffectively is a clearer focus for Sponsors now. Indeed, faster deployment is a key differentiator for this new breed of eCOA providers. So how will they achieve this light-speed deployment?...

Resource

COA White Paper | The Tale of Two Trials

In “The Tale of Two Trials,” Mark Wade takes an in-depth look at the benefits and drawbacks of the traditional, paper-based outcomes assessment method, as well as the advantages of the emerging electronic clinical outcomes assessment (eCOA) solutions. With each having the potential to affect data quality, timelines, and overall trial cost, the choice between them is a much discussed topic....

Resource

LifeSci Talks COA Series | Licensing Challenges vs. eCOA Vendor Capabilities

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacey Higgins, Associate Director, COA & Digital Implementation Team at AbbVie, to cover the intricacies of clinical trial licensing, contract variations among eCOA providers, the importance of sponsor involvement, and the challenges of validated translations. Explore the complexities that can arise in these critical aspects of clinical trials...

Resource

Clinical Content Trends: 2023 Reflections and 2024 Projections

Over the past decade, the pharmaceutical industry has transformed significantly, giving way to breakthrough therapeutics and innovations for improved patient outcomes around the world. With these changes, there’s also been significant developments in the way organizations are approaching business, and with it, the processes that surround managing clinical content. In this webinar, our experts will reflect on some of the most significant insights that 2023 has regarding...

Resource

Achieving Global Success in Clinical Trial Recruitment

TransPerfect's GlobalLink Connect integration with Adobe Experience Cloud enabled one of the world’s largest pharmaceutical companies to help visitors in 17 countries and 13 languages identify clinical trials that might be right for them or their loved ones....

Resource

PRO Scheduling Considerations: Assessing Patient & Caregiver Burden in Clinical Trials

In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Andrew Lloyd, Director at Acaster-Lloyd Consulting, to spotlight the burden of clinical research for patients, and their caregiver/family dynamics. From ethical considerations surrounding patient/caregiver consent, to the intricate timing challenges of data collection, the conversation examines how involvement in a study impacts on disease states and...

Resource

Unlocking the Power of AI and Machine Learning in Life Sciences

Life sciences companies are putting artificial intelligence (AI) and machine learning (ML) into practice, realizing its potential to revolutionize adverse event detection, diagnostics, and more. For AI and ML to be truly effective, you need to give context to your data, teaching the systems to analyze information and improve processes. This is done through data annotation. Discover immediate steps to leverage the power of AI/ML and easy solutions to get you started in this...

Event

C3 Summit London 2024

C3 Summit (Conversations on Clinical Content) is part of a series of events that offers sponsors, CROs, and biotech professionals opportunities to share knowledge, gain industry insights, and network. The series has been celebrated for its casual yet informative format and time-efficient, well curated discussions. Previous panels have featured topics such as inclusivity and diversity in patient recruitment, practical applications of AI/ML, regulatory inspection stories and...

Resource

LifeSci Talks COA Series | Exploring the Intersection of Clinical Practice and Entrepreneurship: Technological Innovation in Clinical Research

In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Dr Michelle Longmire, CEO of Medable, to discuss her journey from clinical practice to entrepreneurship, driven by a passion for rare disease, and the need for technological innovation in clinical research. The conversation highlights key challenges faced in transitioning from academia to entrepreneurship, and the importance of storytelling in...

eCOA LingCert

Access end-to-end consultation, from licensing to electronic clinical outcome assessment (eCOA) migration, and improve the patient and healthcare provider experience with all types of COAs. ...

Resource

An Overview of Generative AI and Machine Translation for Life Sciences

Global life sciences companies are realizing the potential artificial intelligence (AI) and machine learning (ML) has to drive efficiency in content and translation management. To capitalize on this, organizations need to identify the right solutions. Discover important considerations for integrating AI and ML into translation management strategies, steps to get started, and a practical use case in this overview....

Translation & Language Services

Navigate global clinical, corporate, and commercial operations under stringent regulatory compliance requirements while providing fast and accurate multilingual communications....

Resource

Multilingual Labeling: Considerations for Efficient, Cost Effective and Compliance Labeling

Accurate and compliant labeling of an investigational medicinal product (IMP) is an important and integral part of clinical trial operations. A misstep in labeling can lead to significant delays, affecting the entire study’s timeline and potentially incurring costs ranging from $100,000 to $700,000 in hard expenses. In worst-case scenarios, incorrect labeling might necessitate a complete product reproduction. Learn more about the strategies and solutions leading sponsors are...

Event

Engaging Patient Communities: A Pathway to Clinical Trial Success

In this webinar, the expert speakers will focus on the critical role of patient communities in advancing clinical trials. They will explore best practices for engaging with patient communities to enhance recruitment, retention and overall success of the trial. Based on case studies and interactive discussions, attendees will learn how to build trust, foster communication and address the unique needs of patient communities. In a recent study, 91 percent of sites stated they...